{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:10:32Z","timestamp":1785355832027,"version":"3.55.0"},"reference-count":49,"publisher":"American Society for Clinical Investigation","issue":"17","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nation Research Foundation of Korea","award":["2016K1A1A2912057"],"award-info":[{"award-number":["2016K1A1A2912057"]}]},{"name":"European Union Horizon 2020","award":["EUREKA Eurostars 2 grant E!"],"award-info":[{"award-number":["EUREKA Eurostars 2 grant E!"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,8]]},"abstract":"<jats:p>\n                    Huntington\u2019s disease (HD) is a late-onset neurological disorder for which therapeutics are not available. Its key pathological mechanism involves the proteolysis of polyglutamine-expanded (polyQ-expanded) mutant huntingtin (mHTT), which generates N-terminal fragments containing polyQ, a key contributor to HD pathogenesis. Interestingly, a naturally occurring spliced form of\n                    <jats:italic>HTT<\/jats:italic>\n                    mRNA with truncated exon 12 encodes an HTT (HTT\n                    <jats:sup>\u039412<\/jats:sup>\n                    ) with a deletion near the caspase-6 cleavage site. In this study, we used a multidisciplinary approach to characterize the therapeutic potential of targeting HTT exon 12. We show that HTT\n                    <jats:sup>\u039412<\/jats:sup>\n                    was resistant to caspase-6 cleavage in both cell-free and tissue lysate assays. However, HTT\n                    <jats:sup>\u039412<\/jats:sup>\n                    retained overall biochemical and structural properties similar to those of wt-HTT. We generated mice in which HTT exon 12 was truncated and found that the canonical exon 12 was dispensable for the main physiological functions of HTT, including embryonic development and intracellular trafficking. Finally, we pharmacologically induced HTT\n                    <jats:sup>\u039412<\/jats:sup>\n                    using the antisense oligonucleotide (ASO) QRX-704. QRX-704 showed predictable pharmacology and efficient biodistribution. In addition, it was stable for several months and inhibited pathogenic proteolysis. Furthermore, QRX-704 treatments resulted in a reduction of HTT aggregation and an increase in dendritic spine count. Thus, ASO-induced HTT exon 12 splice switching from HTT may provide an alternative therapeutic strategy for HD.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.154108","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:01:32Z","timestamp":1660046492000},"source":"Crossref","is-referenced-by-count":14,"title":["A pathogenic proteolysis\u2013resistant huntingtin isoform induced by an antisense oligonucleotide maintains huntingtin function"],"prefix":"10.1172","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-0323","authenticated-orcid":true,"given":"Hyeongju","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4474-033X","authenticated-orcid":true,"given":"Sophie","family":"Lenoir","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Helfricht","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3862-3433","authenticated-orcid":true,"given":"Taeyang","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea."},{"name":"Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhana K.","family":"Karneva","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0291-516X","authenticated-orcid":true,"given":"Wouter","family":"Beumer","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert B.","family":"van der Horst","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herma","family":"Anthonijsz","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi C.M.","family":"Buil","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"van der Ham","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Platenburg","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Purhonen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3220-9402","authenticated-orcid":true,"given":"Hans","family":"Hebert","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9501-2658","authenticated-orcid":true,"given":"Sandrine","family":"Humbert","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6107-1046","authenticated-orcid":true,"given":"Fr\u00e9d\u00e9ric","family":"Saudou","sequence":"additional","affiliation":[{"name":"University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Klein","sequence":"additional","affiliation":[{"name":"ProQR Therapeutics NV, Leiden, Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-6311","authenticated-orcid":true,"given":"Ji-Joon","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.02.003"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddi147"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4014"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006846"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073902"},{"issue":"3\u20134","key":"B6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddaa283","article-title":"Mutations causing Lopes-Maciel-Rodan syndrome are huntingtin hypomorphs","volume":"30","author":"Jung","year":"2021","journal-title":"Hum Mol Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.06.018"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.12.013"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57552"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5334.1990"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201490808"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.12.030"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1305-11.2012"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.04.026"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199708000-00003"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2071-10.2010"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2019.07.001"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv023"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104943"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127687"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-150151"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/nat.2013.0452"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001475200"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp524"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100886"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.7.4335"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature25502"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2020.06.008"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.7618107"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0715-14.2014"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.06.027"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.11.035"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax3338"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56371"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31759-x"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl467"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-3-17"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610628104"},{"key":"B39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-1221-6_9","article-title":"Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects","volume":"825","author":"Rigo","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn175"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028409"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123527"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddv426"},{"issue":"8","key":"B44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1101\/pdb.top070359","article-title":"Measuring apoptosis: caspase inhibitors and activity assays","volume":"2014","author":"McStay","year":"2014","journal-title":"Cold Spring Harb Protoc"},{"key":"B45","doi-asserted-by":"crossref","unstructured":"Wadman M. Promising drug for Huntington disease fails in major trial. https:\/\/www.science.org\/content\/article\/promising-drug-huntington-disease-fails-major-trial Accessed August 5, 2022","DOI":"10.1126\/science.abi6722"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90542-1"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-155"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.118.6.1333"},{"issue":"6","key":"B49","first-page":"1115","article-title":"A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles","volume":"26","author":"Southwell","year":"2017","journal-title":"Hum Mol Genet"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/154108\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:29:54Z","timestamp":1779146994000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/154108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":49,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,9,8]]}},"alternative-id":["10.1172\/jci.insight.154108"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.154108","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"e154108"}}